BMS-986156, Ipilimumab, and Nivolumab With or Without Stereotactic Body Radiation Therapy in Treating Patients With Advanced or Metastatic Lung/Chest or Liver Cancers

NCT04021043 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

51

Enrollment

OTHER

Sponsor class

Conditions

Advanced Malignant Solid Neoplasm
Metastatic Carcinoma in the Liver
Metastatic Carcinoma in the Lung
Metastatic Malignant Neoplasm in the Thoracic Cavity
Metastatic Malignant Solid Neoplasm

Interventions

DRUG: Anti-GITR Agonistic Monoclonal Antibody BMS-986156
BIOLOGICAL: Ipilimumab
BIOLOGICAL: Nivolumab
RADIATION: Stereotactic Body Radiation Therapy

Sponsor

M.D. Anderson Cancer Center